Search results
Results from the WOW.Com Content Network
Likewise, the Thai government also stepped up its attempt to produce its homegrown vaccines amidst criticism, [9] with "ChulaCov19" and set to begin trials in May 2021. [10] Phase I testing of the NDV-HXP-S vaccine began at Mahidol University in March 2021. [11] [12] In July 2021, the National Vaccine Institute apologized for slow vaccine ...
A private Thai hospital was ordered on Sunday to stop advertising COVID-19 vaccinations for sale in advance on the grounds that no vaccine is yet approved in Thailand. Vibhavadi Hospital told ...
Thai Prime Minister Prayuth Chan-ocha became the first person to be inoculated with the AstraZeneca COVID-19 vaccine in the Southeast Asian country on Tuesday after the rollout had been ...
A leaked health ministry document has prompted calls in Thailand for medical staff inoculated against COVID-19 to be given a booster of an mRNA vaccine, after it included a comment that such a ...
A preventive measure introduced in May; Thai Chana QR-code before entering a retail premise to track individual customers On 12 January, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan, Hubei, China, who had initially come to the attention of the WHO on 31 December 2019.
On 1 March, MOPH reported the first confirmed death in Thailand, a 35-year-old Thai who was originally diagnosed with dengue fever at a private hospital in late January. He was later transferred to Bamrasnaradura Institute on 21 February after testing positive for COVID-19, where he received treatment and had since fully recovered by 16 February.
“Please understand that we can manage this,” Prayuth said as he received the second dose of his coronavirus vaccine. Thai villages isolated over variant find amid vaccine worry Skip to main ...
The Moderna COVID-19 vaccine, also known as Spikevax, [318] is an mRNA vaccine [319] produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.